Lifeboat Foundation

“Why are we impatient? It’s a heritage from our evolution,” says Marc Wittmann, a psychologist at the Institute for Frontier Areas of Psychology and Mental Health in Freiburg, Germany. Impatience made sure we didn’t die from spending too long on a single unrewarding activity. It gave us the impulse to act.

Not long ago I diagnosed myself with the recently identified condition of sidewalk rage. It’s most pronounced when it comes to a certain friend who is a slow walker. Last month, as we sashayed our way to dinner, I found myself biting my tongue, thinking, I have to stop going places with her if I ever want to … get there!

You too can measure yourself on the “Pedestrian Aggressiveness Syndrome Scale,” a tool developed by University of Hawaii psychologist Leon James. While walking in a crowd, do you find yourself “acting in a hostile manner (staring, presenting a mean face, moving closer or faster than expected)” and “enjoying thoughts of violence?”

Continue reading “Why Your Brain Hates Slowpokes” »

The implant acted like scaffolding to bridge over spinal cord injuries.

These technologies sound like something out of a sci-fi movie, but these companies are turning them into a reality.

Epic update suggests big improvements over the current version of Tesla Autopilot, which is already considered very advanced. What exactly does Elon Musk mean by epic though?

Andrew Yang gives a dynamite interview on automation, UBI, and economic solutions to transitioning to the future.

Andrew Yang, award winning entrepreneur, Democratic Presidential candidate, and author of “The War on Normal People,” joins Ben to discuss the Industrial Revolution, Universal Basic Income, climate change, circumcision, and much more.

Continue reading “Andrew Yang | The Ben Shapiro Show Sunday Special Ep. 45” »

A revolutionary 60-minute therapy for high blood pressure could allow patients to throw their tablets away for good.

The unlikely remedy involves blasting nerves in the kidneys with sound waves to stop them sending signals to the brain that drive up blood pressure.

Continue reading “How a blast to the kidney could end high blood pressure for good” »

Now AI doesn’t have to forget everything it learned when it picks up new skills.

More drugmakers are betting gene therapies will have a big impact on patients and profits, with Pfizer Inc. last month agreeing to collaborate with Paris-based Vivet Therapeutics on a treatment for a rare liver disorder. The U.S. Food and Drug Administration forecasts as many as 20 cell- and gene-therapy approvals each year by 2025. Doubts remain about whether the treatments will sustain their dramatic results, making it difficult to determine their value.

Dozens of revolutionary gene therapies that mend faulty strands of DNA are on their way, bringing the power to eliminate lethal childhood diseases, rare blood disorders and other severe illnesses.

Beneath the excitement about these potential cures lies an important catch: no one knows how much to charge for them.

Continue reading “Gene Therapy Was Hailed as a Revolution. Then Came the Bill” »

Some newer info from Aubrey(Especially after 23 min) including published papers, spin out company investing, unity 300 million, and he is confident Project 21 will indeed get rolling in 2021 which is human trials.